From Casetext: Smarter Legal Research

CDX Labs., Inc. v. Zila, Inc.

SUPREME COURT OF THE STATE OF NEW YORK Appellate Division, Second Judicial Department
Jun 27, 2018
162 A.D.3d 972 (N.Y. App. Div. 2018)

Opinion

2016–03519 Index No. 30655/13

06-27-2018

CDX LABORATORIES, INC., et al., appellants, v. ZILA, INC., defendant, Henry Schein, Inc., respondent.

Ellenoff Grossman & Schole, LLP, New York, N.Y. (James K. Landau and Frank Spano of counsel), for appellants. Proskauer Rose, LLP, New York, N.Y. (Jordan B. Leader, Alyse F. Stach, and Kevin Perra of counsel), for respondent.


Ellenoff Grossman & Schole, LLP, New York, N.Y. (James K. Landau and Frank Spano of counsel), for appellants.

Proskauer Rose, LLP, New York, N.Y. (Jordan B. Leader, Alyse F. Stach, and Kevin Perra of counsel), for respondent.

JOHN M. LEVENTHAL, J.P., JEFFREY A. COHEN, ROBERT J. MILLER, JOSEPH J. MALTESE, JJ.

DECISION & ORDER

In an action to recover damages for misappropriation of trade secrets, unfair competition, and tortious interference with business relations, the plaintiffs appeal from an order of the Supreme Court, Rockland County (Victor J. Alfieri, Jr., J.), dated March 7, 2016. The order denied the plaintiffs' motion for leave to amend the complaint to assert a cause of action to recover damages for breach of contract against the defendant Henry Schein, Inc.

ORDERED that the order is affirmed, with costs.

The plaintiffs, CDx Laboratories, Inc. (hereinafter CDx), and Oral Cancer Prevention International, Inc., commenced this action on February 1, 2013, alleging causes of action to recover damages for misappropriation of trade secrets, unfair competition, and tortious interference with business relations. On May 13, 2015, the plaintiffs moved for leave to amend the complaint to assert a cause of action to recover damages for breach of contract against the defendant Henry Schein, Inc. (hereinafter Schein). By order dated March 7, 2016, the Supreme Court denied the motion. The plaintiffs appeal.

"In the absence of prejudice or surprise to the opposing party, leave to amend a pleading should be freely granted unless the proposed amendment is palpably insufficient or patently devoid of merit" ( Mannino v. Wells Fargo Home Mtge. Inc., 155 A.D.3d 860, 862, 65 N.Y.S.3d 66 ; see CPLR 3025[b] ; Assevero v. Hamilton & Church Props., LLC, 154 A.D.3d 728, 62 N.Y.S.3d 163 ; Lucido v. Mancuso, 49 A.D.3d 220, 851 N.Y.S.2d 238 ). " ‘A determination whether to grant such leave is within the Supreme Court's broad discretion, and the exercise of that discretion will not be lightly disturbed’ " ( Finkelstein v. Lincoln Natl. Corp., 107 A.D.3d 759, 761, 967 N.Y.S.2d 733, quoting Gitlin v. Chirinkin, 60 A.D.3d 901, 902, 875 N.Y.S.2d 585 ; see Cullen v. Torsiello, 156 A.D.3d 680, 67 N.Y.S.3d 282 ).

A cause of action alleging breach of contract is governed by a six-year statute of limitations (see CPLR 213[2] ) and accrues at the time of the alleged breach (see Hahn Automotive Warehouse, Inc. v. American Zurich Ins. Co., 18 N.Y.3d 765, 944 N.Y.S.2d 742, 967 N.E.2d 1187 ). Here, even assuming that the relation-back doctrine applies and that the plaintiffs' proposed breach of contract cause of action is deemed interposed at the time that the original complaint was filed (see CPLR 203[1][f] ; O'Halloran v. Metropolitan Transp. Auth., 154 A.D.3d 83, 86, 60 N.Y.S.3d 128 ; Cady v. Springbrook NY, Inc., 145 A.D.3d 846, 846–847, 44 N.Y.S.3d 107 ), the statute of limitations for asserting that cause of action has expired. The proposed amended complaint alleges only that Schein breached a certain agreement with CDx "regularly," "[b]eginning in or around 2002." No allegations are made, and the plaintiffs' evidence otherwise fails to establish, that Schein breached the agreement within the six years immediately preceding the filing of the original complaint; that is, after February 1, 2007 (see CPLR 213[2] ). Accordingly, the plaintiffs' motion for leave to amend the complaint was properly denied (see Cady v. Springbrook NY, Inc., 145 A.D.3d 846, 44 N.Y.S.3d 107 ; Carroll v. Motola, 109 A.D.3d 629, 630, 970 N.Y.S.2d 820 ; Fisher v. Giuca, 69 A.D.3d 671, 893 N.Y.S.2d 184 ; Clark v. Foley, 240 A.D.2d 458, 658 N.Y.S.2d 429 ; cf. Katz v. Beil, 142 A.D.3d 957, 39 N.Y.S.3d 157 ).

LEVENTHAL, J.P., COHEN, MILLER and MALTESE, JJ., concur.


Summaries of

CDX Labs., Inc. v. Zila, Inc.

SUPREME COURT OF THE STATE OF NEW YORK Appellate Division, Second Judicial Department
Jun 27, 2018
162 A.D.3d 972 (N.Y. App. Div. 2018)
Case details for

CDX Labs., Inc. v. Zila, Inc.

Case Details

Full title:CDx Laboratories, Inc., et al., appellants, v. Zila, Inc., defendant…

Court:SUPREME COURT OF THE STATE OF NEW YORK Appellate Division, Second Judicial Department

Date published: Jun 27, 2018

Citations

162 A.D.3d 972 (N.Y. App. Div. 2018)
162 A.D.3d 972
2018 N.Y. Slip Op. 4693

Citing Cases

Zapeta v 5214 15 Ave Dev. LLC

Consequently, plaintiff argues that his motion to amend should be granted since both Prestige and Signature…

Feng Xue v. Koenig

Pursuant to New York Civil Practice Law and Rules ("CPLR") § 213(2), "[a] cause of action alleging breach of…